Medication-Assisted Treatment for Fentanyl Addiction in Austin

Checkmark Icon Medically Reviewed

More Time. More Joy. More You. Start Now.

WE ACCEPT MOST INSURANCES

Last Updated on September 26, 2026

Yes, medication-assisted treatment options for fentanyl addiction are available in Austin through Nova Recovery Center’s outpatient and residential programs. Fentanyl—a synthetic opioid 50 to 100 times more potent than morphine—creates profound physiological dependence that typically requires FDA-approved medications alongside counseling and behavioral therapies. Nova Recovery Center delivers MAT protocols using buprenorphine, naltrexone, and other evidence-based medications within both our Austin outpatient clinic and our residential treatment settings in Austin and nearby Wimberley.

If you or someone you love needs more than detox, Nova Recovery Center also provides drug rehab austin.

Nova Recovery Center’s evidence-based addiction treatment program provides medically supervised, evidence-based care.

Why Medication-Assisted Treatment Is Essential for Fentanyl Use Disorder

Fentanyl withdrawal produces severe physical symptoms—muscle pain, nausea, insomnia, agitation—that peak within 12 to 30 hours after the last dose and persist for days. Without pharmacological intervention, relapse rates exceed 80 percent within the first month. Medication-assisted treatment for fentanyl addiction addresses both the neurobiological dysregulation caused by chronic opioid exposure and the overwhelming cravings that derail early recovery.

The American Society of Addiction Medicine and the Substance Abuse and Mental Health Services Administration identify MAT as the gold standard for opioid use disorder. Research demonstrates that patients receiving buprenorphine or naltrexone remain in treatment longer, reduce illicit opioid use more consistently, and experience lower overdose mortality compared to counseling-only approaches.

Nova Recovery Center’s clinical team recognizes that fentanyl’s extreme potency complicates induction onto buprenorphine. Traditional Suboxone protocols can precipitate acute withdrawal if residual fentanyl occupies opioid receptors when buprenorphine is introduced. Our physicians use extended observation, symptom monitoring with Clinical Opiate Withdrawal Scale assessments, and micro-dosing techniques to safely transition patients from fentanyl to maintenance medications.

FDA-Approved Medications Used in Austin MAT Programs

Three medication classes anchor medication-assisted treatment for fentanyl addiction available in Austin through Nova Recovery Center. Each functions through distinct mechanisms and fits different clinical scenarios.

Buprenorphine (Suboxone, Subutex, Sublocade) is a partial opioid agonist that binds tightly to mu-opioid receptors, blocking fentanyl’s euphoric effects while reducing cravings and withdrawal. Sublingual films and tablets provide daily dosing; monthly Sublocade injections eliminate the risk of diversion and improve adherence. Buprenorphine carries lower overdose risk than full agonists like methadone and allows patients to function normally in work and family settings.

Naltrexone (Vivitrol, oral naltrexone) is a full opioid antagonist that completely blocks opioid receptor activation. Monthly Vivitrol injections prevent relapse by rendering fentanyl ineffective if used. Naltrexone requires complete detoxification before initiation—typically seven to ten days of abstinence from short-acting opioids, longer for fentanyl due to lipid storage. It suits patients who prefer an abstinence-based model or have contraindications to agonist therapy.

Methadone is a full opioid agonist dispensed only through federally certified opioid treatment programs. While highly effective for severe opioid dependence, it requires daily clinic visits during stabilization. Nova Recovery Center coordinates referrals to licensed methadone clinics when clinical assessment indicates this level of structure benefits the patient, though our primary MAT delivery uses buprenorphine and naltrexone within our treatment framework.

How Nova Recovery Center Delivers MAT in Austin

Medication-assisted treatment for fentanyl addiction available in Austin through Nova Recovery Center integrates pharmacotherapy with intensive counseling, group therapy, and case management. Our outpatient program in Austin offers three levels of care intensity.

Intensive Outpatient (IOP) meets nine hours weekly across three sessions. Patients receive individual therapy, process groups focused on relapse prevention and coping skills, and medication management appointments with our prescribing physicians. IOP accommodates work and family obligations while delivering structured support during early recovery.

Outpatient (OP) steps down to six hours weekly for patients stabilized on medication who demonstrate consistent abstinence and recovery capital. OP maintains therapeutic momentum and medication oversight while increasing independence.

Medication management provides ongoing prescribing, urine drug screening, and brief check-ins for patients who have completed formal programming but require continued pharmacotherapy. This level prevents gaps in medication access that precipitate relapse.

For patients requiring medical detoxification or 24-hour structure, Nova Recovery Center’s residential programs in Austin and Wimberley initiate MAT within a controlled environment. Residential placement allows careful buprenorphine induction, manages co-occurring psychiatric conditions, and removes environmental triggers during the vulnerable first weeks. After residential stabilization, patients transition to Austin outpatient care with continuous medication protocols.

Clinical Assessment and Individualized MAT Planning

No single medication suits every patient. Nova Recovery Center’s intake process includes detailed substance use history, physical examination, review of prior treatment episodes, mental health screening, and discussion of patient preferences. Factors influencing medication selection include:

  • Severity and duration of fentanyl use
  • Previous MAT experience and response
  • Co-occurring mental health diagnoses (depression, anxiety, PTSD)
  • Pregnancy or plans for pregnancy
  • Liver function and medical comorbidities
  • Risk of diversion or misuse
  • Insurance coverage and formulary restrictions
  • Patient motivation and treatment goals

Patients using fentanyl heavily or recently often begin with buprenorphine due to its safety profile and flexibility. Those who have completed medically supervised withdrawal or come from controlled environments like incarceration may choose naltrexone to avoid any agonist exposure. Our physicians adjust medications and dosages throughout treatment based on cravings, withdrawal symptoms, drug screen results, and functional outcomes.

Addressing Barriers to MAT Access in Austin

Despite strong evidence, medication-assisted treatment for fentanyl addiction remains underutilized. Stigma persists—some view MAT as “replacing one drug with another” rather than recognizing it as medical management of a chronic brain disease. Family members and patients sometimes resist medication, preferring abstinence-only models that carry higher relapse and mortality risk for opioid dependence.

Nova Recovery Center educates patients and families that MAT corrects neurochemical imbalances created by prolonged opioid exposure. Buprenorphine and naltrexone do not produce euphoria at therapeutic doses; they restore baseline brain function, allowing engagement in therapy and rebuilding of life structure. Duration of MAT varies—some patients benefit from six to twelve months of medication, others require years, and some maintain indefinitely, similar to management of diabetes or hypertension.

Insurance coverage has expanded significantly under mental health parity laws. Most commercial plans, Medicare, and Medicaid cover FDA-approved MAT medications and the associated counseling. Nova Recovery Center verifies benefits before admission, identifies prior authorization requirements, and works with patients to minimize out-of-pocket costs. For those without coverage, payment plans make treatment accessible.

Integrating Counseling and Behavioral Therapies With Medication

Medication stabilizes brain chemistry; therapy addresses the behavioral, psychological, and social dimensions of addiction. Nova Recovery Center’s clinical programming combines MAT with evidence-based psychotherapies proven effective for opioid use disorder.

Cognitive Behavioral Therapy (CBT) identifies thought patterns and triggers that precede drug use, then builds coping strategies to interrupt the craving-use cycle. Patients practice refusal skills, develop relapse prevention plans, and restructure cognitive distortions that rationalize use.

Motivational Interviewing resolves ambivalence about recovery and medication adherence. Many fentanyl users enter treatment with external pressure from family or legal systems. MI techniques strengthen intrinsic motivation and commitment to change.

Trauma-informed care recognizes the high prevalence of adverse childhood experiences and PTSD among individuals with opioid dependence. Our therapists screen for trauma, create safety in therapeutic relationships, and use modalities like EMDR when indicated.

Group therapy reduces isolation, normalizes recovery challenges, and fosters peer accountability. Process groups, relapse prevention groups, and 12-step facilitation groups meet multiple times weekly in our IOP and OP tracks.

Family education sessions help loved ones understand fentanyl addiction as a medical condition, set healthy boundaries, and support recovery without enabling. Family involvement improves retention and outcomes, particularly for younger adults.

Monitoring Progress and Adjusting Treatment

Recovery from fentanyl addiction unfolds over months and years. Nova Recovery Center tracks multiple outcome measures beyond abstinence: employment, housing stability, legal involvement, mental health symptoms, social support, and quality of life. Medication management appointments occur weekly initially, then bi-weekly or monthly as stability increases.

Urine drug screens verify abstinence from illicit opioids and other substances while confirming medication adherence. Fentanyl metabolites can remain detectable for days after use; our lab uses high-sensitivity assays to distinguish prescribed buprenorphine from illicit fentanyl. Positive screens prompt clinical reassessment rather than punitive discharge—we increase treatment intensity, address barriers to medication adherence, or adjust dosing.

Relapse, if it occurs, is met with compassionate re-engagement. Our team evaluates what precipitated the lapse, whether current medications remain appropriate, and what additional supports might prevent recurrence. Some patients benefit from stepping up to residential care; others need stronger community linkages or treatment of undiagnosed mental health conditions.

Long-Term Medication-Assisted Treatment and Sustained Recovery

Duration of medication-assisted treatment for fentanyl addiction available in Austin varies widely based on individual needs. Clinical guidelines recommend a minimum of 12 months; many patients continue longer. Premature discontinuation correlates with higher relapse rates. Our physicians work collaboratively with patients to determine the optimal duration, tapering medications only when recovery is firmly established and the patient demonstrates readiness.

Some individuals maintain on buprenorphine or naltrexone indefinitely. This is neither failure nor dependence—it is evidence-based chronic disease management. Fentanyl exposure alters brain reward circuitry for years after last use; medication protects against these enduring vulnerabilities while patients build lives worth protecting.

Nova Recovery Center’s continuum of care supports patients through every phase. After completing IOP or residential treatment, patients transition to outpatient counseling with continued medication management. Alumni services, sober support groups, and care coordination maintain connection and provide rapid re-intervention if warning signs emerge. We treat opioid use disorder as the chronic, relapsing condition it is—offering sustained, flexible support rather than time-limited episodes.

If you or someone you care about is struggling with fentanyl addiction, medication-assisted treatment offers a proven path forward. Nova Recovery Center’s Austin team is ready to answer questions, verify insurance benefits, and begin the assessment process.

Ready to take the next step?

Nova Recovery Center provides inpatient and outpatient drug & alcohol rehab. Call (512) 893-6955 to speak with our team today.

Frequently Asked Questions

What is medication assisted treatment for opioid use disorder?
Medication-assisted treatment (MAT) combines FDA-approved medications like buprenorphine, naltrexone, or methadone with counseling and behavioral therapies to treat opioid use disorder. The medications reduce cravings and withdrawal symptoms, normalize brain chemistry disrupted by chronic opioid use, and block the euphoric effects of opioids. MAT is considered the gold standard for opioid addiction treatment and significantly improves retention in treatment and reduces overdose deaths.
What is the gold standard treatment for opioid use disorder?
The gold standard treatment for opioid use disorder is medication-assisted treatment that combines FDA-approved medications (buprenorphine, methadone, or naltrexone) with counseling and behavioral therapies. This integrated approach addresses both the neurobiological changes caused by opioid dependence and the psychological and social factors driving addiction. Research consistently shows MAT produces better outcomes than counseling alone, including higher treatment retention, reduced illicit opioid use, and lower mortality.
What is oud treatment?
OUD treatment refers to treatment for opioid use disorder, the clinical diagnosis for opioid addiction. Effective OUD treatment includes medication-assisted treatment using buprenorphine, naltrexone, or methadone combined with individual counseling, group therapy, case management, and support services. Treatment intensity varies from residential programs to intensive outpatient and standard outpatient levels of care. The goal is sustained recovery, improved functioning, and reduced risk of overdose and death.
What are the alternatives to Suboxone for treating opioid use disorder?
Alternatives to Suboxone for treating opioid use disorder include Sublocade (monthly buprenorphine injection), Subutex (buprenorphine without naloxone), Vivitrol (monthly naltrexone injection), oral naltrexone, and methadone. Sublocade eliminates daily dosing and diversion risk. Naltrexone products work well for patients who have completed detoxification and prefer an abstinence-based approach. Methadone is highly effective for severe opioid dependence but requires daily clinic visits initially.
Which is safer, Subutex or Suboxone?
Suboxone and Subutex have comparable safety profiles since both contain buprenorphine as the active ingredient. Suboxone adds naloxone to deter intravenous misuse—if injected, naloxone precipitates withdrawal, whereas Subutex contains only buprenorphine. Subutex is sometimes prescribed during pregnancy since naloxone's safety in pregnancy is less established, though current evidence suggests minimal risk. Both medications carry low overdose risk when used as prescribed and are far safer than continued fentanyl use.
How does naltrexone help with opioid addiction?
Naltrexone helps with opioid addiction by completely blocking opioid receptors in the brain, preventing any euphoric or rewarding effects if opioids are used. This eliminates the incentive to use fentanyl or other opioids. Monthly Vivitrol injections provide consistent receptor blockade, reducing relapse risk. Naltrexone does not produce physical dependence or withdrawal and suits patients who have completed detoxification and prefer a non-agonist medication approach.
What is the newest treatment for opioid addiction?
The newest FDA-approved treatment for opioid addiction is Sublocade, a monthly buprenorphine injection approved in 2017. It provides steady medication levels without daily dosing, improving adherence and eliminating diversion risk. Other recent advances include rapid micro-induction protocols for transitioning from fentanyl to buprenorphine and low-dose naltrexone bridging strategies. Research continues on longer-acting formulations and novel medications targeting different neural pathways, though buprenorphine and naltrexone remain the primary evidence-based medications.
How long does medication-assisted treatment for fentanyl addiction last?
The duration of medication-assisted treatment for fentanyl addiction varies by individual needs but typically lasts at least 12 months. Many patients benefit from longer-term or indefinite medication maintenance, similar to management of chronic conditions like diabetes. Premature discontinuation increases relapse risk. Treatment length depends on factors including severity of addiction, co-occurring mental health conditions, stability in recovery, and patient readiness. Physicians work collaboratively with patients to determine optimal duration and taper timing when appropriate.

VERIFY YOUR INSURANCE TODAY! (FREE & CONFIDENTIAL)

=
Dr. Robert Ulrich

Dr. Robert Ulrich

Medical Director | Nova Recovery Center

Dr. Robert Ulrich serves as Medical Director at Nova Recovery Center, bringing more than two decades of clinical neurology experience to the treatment of substance use disorders. He is board-certified in neurology by the American Board of Psychiatry and Neurology and completed his neurology residency at UT Southwestern Medical Center in Dallas, where he served as Chief Resident.

Throughout his career in neurology, Dr. Ulrich observed that many patients with neurological conditions also faced challenges related to substance use. In late 2022, he shifted his clinical focus toward addiction medicine, applying his extensive knowledge of brain function, neurochemistry, and the central nervous system to support individuals in recovery.

As Medical Director, Dr. Ulrich provides clinical leadership and helps guide the medical services delivered at Nova Recovery Center. His background in neurology allows him to approach addiction treatment with a detailed understanding of the neurological, physical, and behavioral factors that influence substance use and recovery.

Dr. Ulrich works closely with the clinical team to support individualized, evidence-based treatment plans designed to promote patient safety, stability, and long-term recovery.

Anna-Grace Washington

Medical Content Strategist

Anna-Grace Washington is a Medical Content Writer for Nova Recovery Center. She holds a master’s degree in clinical psychology from the University of Texas and brings a strong understanding of behavioral health, addiction recovery, and evidence-based treatment concepts to her writing. Through her work, Anna-Grace helps create clear, accurate, and compassionate content for individuals and families seeking information about substance use disorders, mental health, and long-term recovery. Her writing reflects Nova Recovery Center’s commitment to education, support, and clinically informed care.
Call Now Button